Abbott Laboratories (ABT) 10-K Summary — Year Ended Dec 31, 2024
Abbott Laboratories described its business and risks in its annual report. The company reported a revenue increase and higher operating income and net income compared to the prior period.
Key takeaway
Year ended Dec 31, 2024 · FY2025 10-K
Abbott Laboratories described its business and risks in its annual report. The company reported a revenue increase and higher operating income and net income compared to the prior period.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$42B
Revenue reported for the fiscal year.
Operating income
$6.8B
Income from operations reported for the year.
Net income
$13.4B
Net income reported for the year.
Operating cash flow
$8.6B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $43.1B | n/a |
| Dec 31, 2022 | $43.7B | +1.3% |
| Dec 31, 2023 | $40.1B | -8.1% |
| Dec 31, 2024 | $42B | +4.6% |
Business overview
Abbott Laboratories operates as a diversified healthcare company. The filing covers its business overview, risk factors, and management discussion. The company addresses cybersecurity and unresolved staff comments in its business description.
Financial performance
Revenue for the year increased compared to the previous year. Operating income and net income also showed improvement. Operating cash flow was reported at a level consistent with strong operational performance.
Material risks
The filing identifies risk factors under Item 1A that may affect operations, including unresolved staff comments and cybersecurity matters. These risks could impact financial results or business continuity. The company does not specify the probability or magnitude of these risks.
Liquidity and capital
The filing includes a management discussion of financial condition and results of operations, but does not provide specific capital allocation strategies or liquidity plans beyond operational cash flow.
What to watch
Readers should monitor how the company addresses unresolved staff comments and cybersecurity risks in the next filing.